Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Investigational New Drugs|July 27, 2013
Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cellsMancang Gu, Yanke Yu, G M Kamal B Gunaherath, et al.Molecular Pharmaceutics|September 18, 2010
Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug releasePeng Zou, Yanke Yu, Y Andrew Wang, et al.The Science of the Total Environment|November 27, 2012
Spatial distribution and sources identification of elements in PM2.5 among the coastal city group in the Western Taiwan Strait region, ChinaLingling Xu, Yanke Yu, Jianshuan Yu, et al.Journal of Clinical Pharmacology|May 30, 2020
Exposure-Safety Analyses of Talazoparib in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations in the EMBRACA and ABRAZO TrialsMohamed Elmeliegy, Yanke Yu, Jennifer K Litton, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 13, 2020
A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitorWenbo Chen, Britton Boras, Tae Sung, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 15, 2012
Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokineticsPeng Zou, Nan Zheng, Yanke Yu, et al.The Journal of Biological Chemistry|April 24, 2010
Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactionsYiqun Jiang, Denzil Bernard, Yanke Yu, et al.International Journal of Medical Sciences|November 18, 2021
Assessment of the Utility of Physiologically-based Pharmacokinetic Model for prediction of Pharmacokinetics in Chinese and Japanese PopulationsYanke Yu, Jian Lin, Chieko Muto, et al.Journal of Clinical Pharmacology|May 18, 2017
The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation EvaluationDiane D Wang, Yanke Yu, Nastya Kassir, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 20, 2023
Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc)Yanke Yu, Michael E Rothenberg, Han Ting Ding, et al.Pageof 6